Localized Cutaneous Adverse Event Induced by Anastrozole as Adjuvant Treatment for Breast Cancer: A Case Report

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Localized Cutaneous Adverse Event Induced by Anastrozole as Adjuvant Treatment for Breast Cancer: A Case Report ; volume:11 ; number:1 ; year:2019 ; pages:57-63
Case reports in dermatology ; 11, Heft 1 (2019), 57-63

Creator: Tanaka, Aya
Yamashita, Chigusa
Hinogami, Haruna
Shirai, Hirohiko
Yamamura, Jun
Ito, Ryota

DOI: 10.1159/000497469

URN: urn:nbn:de:101:1-2019051601192033145245

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 2025-08-14T10:50:08+0200

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Tanaka, Aya
Yamashita, Chigusa
Hinogami, Haruna
Shirai, Hirohiko
Yamamura, Jun
Ito, Ryota

Other Objects (12)

Cutaneous adverse events associated with interferon-β treatment of multiple sclerosis

Cutaneous adverse events associated with long-term immunomodulating therapy in multiple sclerosis

Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review

CACA guidelines for holistic integrative management of anticancer treatment - induced cutaneous adverse events

Aufsatzsammlung

Adverse cutaneous drug eruptions : 34 tables

Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases

Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany

Concomitant visceral and localized cutaneous leishmaniasis in two Moroccan infants

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction

Management of immune-related adverse events in anti-PD-1-treated patients with advanced cutaneous squamous cell carcinoma

Cutaneous adverse events associated with interferon-β treatment of multiple sclerosis

Cutaneous adverse events associated with long-term immunomodulating therapy in multiple sclerosis

Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review

CACA guidelines for holistic integrative management of anticancer treatment - induced cutaneous adverse events

Aufsatzsammlung

Adverse cutaneous drug eruptions : 34 tables

Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases

Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany

Concomitant visceral and localized cutaneous leishmaniasis in two Moroccan infants

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction

Management of immune-related adverse events in anti-PD-1-treated patients with advanced cutaneous squamous cell carcinoma

Cutaneous adverse events associated with interferon-β treatment of multiple sclerosis

Cutaneous adverse events associated with long-term immunomodulating therapy in multiple sclerosis

Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review

CACA guidelines for holistic integrative management of anticancer treatment - induced cutaneous adverse events

Aufsatzsammlung

Adverse cutaneous drug eruptions : 34 tables

Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases

Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany

Concomitant visceral and localized cutaneous leishmaniasis in two Moroccan infants

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction

Management of immune-related adverse events in anti-PD-1-treated patients with advanced cutaneous squamous cell carcinoma

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Localized Cutaneous Adverse Event Induced by Anastrozole as Adjuvant Treatment for Breast Cancer: A Case Report

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Cutaneous adverse events associated with interferon-β treatment of multiple sclerosis

Cutaneous adverse events associated with long-term immunomodulating therapy in multiple sclerosis

Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review

CACA guidelines for holistic integrative management of anticancer treatment - induced cutaneous adverse events

Adverse cutaneous drug eruptions : 34 tables

Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases

Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany

Concomitant visceral and localized cutaneous leishmaniasis in two Moroccan infants

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction

Management of immune-related adverse events in anti-PD-1-treated patients with advanced cutaneous squamous cell carcinoma

Cutaneous adverse events associated with interferon-β treatment of multiple sclerosis

Cutaneous adverse events associated with long-term immunomodulating therapy in multiple sclerosis

Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review

CACA guidelines for holistic integrative management of anticancer treatment - induced cutaneous adverse events

Adverse cutaneous drug eruptions : 34 tables

Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases

Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany

Concomitant visceral and localized cutaneous leishmaniasis in two Moroccan infants

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction

Management of immune-related adverse events in anti-PD-1-treated patients with advanced cutaneous squamous cell carcinoma

Cutaneous adverse events associated with interferon-β treatment of multiple sclerosis

Cutaneous adverse events associated with long-term immunomodulating therapy in multiple sclerosis

Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review

CACA guidelines for holistic integrative management of anticancer treatment - induced cutaneous adverse events

Adverse cutaneous drug eruptions : 34 tables

Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases

Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany

Concomitant visceral and localized cutaneous leishmaniasis in two Moroccan infants

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction

Management of immune-related adverse events in anti-PD-1-treated patients with advanced cutaneous squamous cell carcinoma

Related objects

Reset password